Medicare Enrolled
Dr. Robert Garbacz, D.O.
Dermatology · Wichita Falls, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Garbacz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garbacz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Garbacz
Dr. Robert Garbacz is a dermatology specialist in Wichita Falls, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Garbacz performed 31,922 Medicare services across 6,329 unique beneficiaries.
Between the years covered by Open Payments, Dr. Garbacz received a total of $4,247 from 26 pharmaceutical and/or device companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Garbacz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in TX
$4,247 industry payments
Medicare Practice Summary
Medicare Utilization ↗31,922
Medicare services
Top 1% in TX for dermatology
6,329
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,596 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Photodynamic therapy gel for precancerous skin | 18,600 | $1 | $4 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,154 | $5 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,850 | $59 | $197 |
| Superficial or low voltage radiation treatment A radiation therapy procedure that delivers radiation to the surface of the body or uses low voltage energy. This treatment targets areas close to the skin. |
1,768 | $30 | $89 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
1,091 | $53 | $156 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
902 | $40 | $123 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
739 | $66 | $222 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
644 | $39 | $147 |
| Radiation treatment planning, 1 area This procedure involves gathering the necessary data to design the most effective radiation therapy plan for a single treatment area. |
499 | $202 | $586 |
| Ultraviolet light skin treatment Application of ultraviolet light to the skin for therapeutic purposes. |
485 | $16 | $53 |
| Ultrasound guidance for radiation therapy field placement Use of ultrasound imaging to help position radiation therapy fields accurately during treatment. |
355 | $135 | $392 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
282 | $66 | $244 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
276 | $76 | $248 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
268 | $38 | $110 |
| Calculation of radiation therapy dose | 256 | $49 | $144 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
234 | $1 | $2 |
| Design and construction of complex radiation treatment device This code covers the design and construction of a complex radiation treatment device. It does not specify the clinical purpose or conditions treated. |
194 | $94 | $273 |
| Radiation treatment planning, complex This procedure involves obtaining the necessary data to develop an optimal radiation treatment plan for three or more treatment areas, or any number of areas requiring special treatment. |
130 | $330 | $984 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
114 | $82 | $280 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
92 | $198 | $613 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
91 | $44 | $157 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
80 | $204 | $666 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 80 | $207 | $692 |
| Removal of inflamed or infected skin, up to 10% of body surface This procedure involves the surgical removal of skin affected by inflammation or infection. It is performed when the affected area covers up to 10 percent of the patient's total body surface area. |
75 | $43 | $127 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
74 | $33 | $125 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
70 | $51 | $211 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
61 | $9 | $31 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
58 | $105 | $586 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
42 | $32 | $92 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
35 | $138 | $423 |
| Destruction of cancerous skin growth, 3.1-4.0 cm This procedure involves the removal or destruction of a cancerous skin lesion on the trunk, arms, or legs that measures between 3.1 and 4.0 centimeters. |
31 | $145 | $453 |
| Acne surgery A surgical procedure to treat acne. The specific techniques and extent of the surgery are not defined in this general code description. |
26 | $74 | $255 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
26 | $95 | $536 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
26 | $136 | $392 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
25 | $87 | $276 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
25 | $175 | $680 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
22 | $109 | $370 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
21 | $152 | $452 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
17 | $114 | $610 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 16 | $142 | $414 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
15 | $104 | $553 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
13 | $66 | $376 |
| Destruction of skin growth, 15 or more growths | 13 | $99 | $290 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | 13 | $156 | $458 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $93 | $364 |
| Removal of noncancer skin growth, larger than 4.0 cm This procedure involves the surgical removal of a benign skin growth located on the scalp, neck, hands, feet, or genitals. The growth being removed is larger than 4.0 centimeters in size. |
11 | $255 | $723 |
| Skin cancer removal, face/ears/eyes/nose/lips, 2.1-3.0 cm Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 2.1 and 3.0 centimeters. |
11 | $144 | $690 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
14.6% medium
85.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,247
Total received (2018-2024)
Avg $607/year across 7 years
Top 46% in TX for dermatology
26
Companies
250
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,058 (95.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$188 (4.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$938
2023
$596
2022
$684
2021
$712
2020
$460
2019
$455
2018
$402
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$798
Lilly USA, LLC
$460
Janssen Biotech, Inc.
$422
Biofrontera Inc.
$359
PFIZER INC.
$301
Novartis Pharmaceuticals Corporation
$258
Sun Pharmaceutical Industries Inc.
$224
GENZYME CORPORATION
$179
SUN PHARMACEUTICAL INDUSTRIES INC.
$165
AbbVie Inc.
$157
E.R. Squibb & Sons, L.L.C.
$150
Celgene Corporation
$138
ABBVIE INC.
$114
Galderma Laboratories, L.P.
$75
Incyte Corporation
$62
AbbVie, Inc.
$55
Verrica Pharmaceuticals Inc.
$54
Dermavant Sciences, Inc.
$54
DUSA Pharmaceuticals, Inc.
$44
Paratek Pharmaceuticals, Inc.
$42
Amgen Inc.
$34
Merck Sharp & Dohme Corporation
$25
Almirall LLC
$23
Regeneron Healthcare Solutions, Inc.
$20
REVANCE THERAPEUTICS, INC.
$19
Genentech USA, Inc.
$17
Top 3 companies account for 39.6% of total payments
Associated products mentioned in payments ›
20% · ABSORICA LD · AKLIEF · AMELUZ · Absorica LD · Ameluz · BLU-U · Bimzelx · COSENTYX · Cimzia · DAXXIFY · DUPIXENT · EPIDUO FORTE · EUCRISA · HUMIRA · Humira · ILUMYA · Ilumya · LEVULAN KERASTICK · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · NUZYRA · OPZELURA · Odomzo · Otezla · REMICADE · SIVEXTRO · SKYRIZI · STELARA · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VTAMA · Xolair · YCANTH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $13 per 100 Medicare services performed
Geographic Context
Dermatologists within 10 mi
4
Per 100K population
3.1
County median income
$62,168
Nearest hospital
NORTH TEXAS STATE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Garbacz is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Garbacz experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Garbacz performed 18,600 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Garbacz receive payments from pharmaceutical companies?
Yes. Dr. Garbacz received a total of $4,247 from 26 companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garbacz's costs compare to other dermatologists in Wichita Falls?
Dr. Garbacz's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garbacz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Wichita Falls
Browse dermatologists in Wichita Falls ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in TX
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in TX
Which TX dermatologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology